Canada Biotechnology & Medical Research

Revive Therapeutics Ltd (RVV)

Track

Track

Ticker: RVV Exchange: CNX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Lindzon, Andrew Stuart Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
308.09
Quantity 68,748 +32.1%
Value CA$4,880,892
Frank, Michael Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
323.20
Quantity 60,728 -31.4%
Value CA$77,906
Frank, Michael Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
197.56
Quantity 55,169 +40.6%
Value CA$3,649,514
Frank, Michael Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.04
Quantity 150,000 +6.3%
Value CA$5,250
Frank, Michael Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.03
Quantity 18,000 +0.8%
Value CA$540
Frank, Michael Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
0.03
Quantity 254,000
Value CA$7,620
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-11 2024-07-10 B Purchase
Lindzon, Andrew Stuart

Director of Issuer

Non-Executive Director
68,748 +32.1%
308.09
CA$4,880,892 		68,748 +32.1% 308.09 CA$4,880,892
2024-07-03 2024-07-03 B Purchase
Frank, Michael

Director of Issuer, Senior Officer of Issuer

Executive Director
60,728 -31.4%
323.20
CA$77,906 		60,728 -31.4% 323.20 CA$77,906
2024-03-19 2024-03-19 B Purchase
Frank, Michael

Director of Issuer, Senior Officer of Issuer

Executive Director
55,169 +40.6%
197.56
CA$3,649,514 		55,169 +40.6% 197.56 CA$3,649,514
2024-03-18 2024-03-18 B Purchase
Frank, Michael

Director of Issuer, Senior Officer of Issuer

Executive Director
150,000 +6.3%
0.04
CA$5,250 		150,000 +6.3% 0.04 CA$5,250
2024-03-15 2024-03-15 B Purchase
Frank, Michael

Director of Issuer, Senior Officer of Issuer

Executive Director
18,000 +0.8%
0.03
CA$540 		18,000 +0.8% 0.03 CA$540
2024-03-15 2024-03-15 B Purchase
Frank, Michael

Director of Issuer, Senior Officer of Issuer

Executive Director
254,000
0.03
CA$7,620 		254,000 0.03 CA$7,620
Explore more

More insider trading research around Revive Therapeutics Ltd

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America